Insider Cluster (3 insiders) ·Filed Feb 23, 2026

VERA

Vera Therapeutics, Inc.
BEARISH
Impact 6/10
Horizondays Processed7mo ago
Insider cluster: 3 insiders, $0.3M total
Actionable Insight ▼ Bearish

Coordinated C-suite selling, especially in the absence of recent buying, may signal lack of confidence in near-term prospects. Traders should monitor upcoming earnings, pipeline updates, or potential financing activity that could dilute shares.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
VERA ▼ -18.33% at T+60d
SHORT call ✓ call won +18.33% · α vs SPY +26.58% · entry $42.06 → $34.35
Entry anchored
Feb 20, 03:59 PM ET
via exchange tick
T+1d
+0.74%
call -0.74% · α -0.00%
$42.37
settled 7mo ago
T+5d
-3.90%
call +3.90% · α +4.52%
$40.42
settled 7mo ago
T+20d
-3.16%
call +3.16% · α -0.78%
$40.73
settled 7mo ago
T+60d
-18.33%
call +18.33% · α +26.58%
$34.35
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Three senior executives at Vera Therapeutics — the Chief Regulatory Officer, Chief Operating Officer, and Chief Commercial Officer — collectively sold over $266,000 worth of shares in a coordinated open-market transaction on February 23, 2026. All trades occurred at the same price, indicating a planned selling event, though no material non-public information is indicated by the timing.

Key Financial Metrics

Direction
selling
Total Value
$266.5K
Insiders
3

Key Facts

  • Three C-suite executives sold shares simultaneously on February 23, 2026.
  • Total value of sales: $266,513.79 across 6,348 shares.
  • All transactions were open-market sales (Form 4 'S' codes) at identical price: $41.9839 per share.
  • Sellers include Chief Commercial Officer, Chief Operating Officer, and Chief Regulatory Officer — all key operational leaders.

Financial Impact

$266,514 in insider selling over one day

insider ownershipinvestor sentimentpotential dilution signal

Risk Factors

  • Potential perception of insider pessimism ahead of a catalyst or earnings release.
  • Possible upcoming stock offering or financing that insiders are preemptively hedging against.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (3 trades, 7d window)cluster-VERA-1772067485262
17 reports for VERA
Performance horizon
100% Hit rate 11 of 11 directional calls best @ T+20▲ +36.47%Jun 2, 2026
Filters
Rows
Reports for VERA — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
8-K
BULLISH ★ 8/10
$33.67 $34.00▲ +0.98%▲ +0.16%$30.13 (−10.53%)
Aug 10, 2026
7w ago
8-K
NEUTRAL ★ 5/10
$30.29 $32.28▲ +6.57%▲ +6.97%$30.13 (−0.54%)
Aug 10, 2026
7w ago
Press Release
MIXED ★ 7/10
$30.29 $32.28▲ +6.57%▲ +6.97%$30.13 (−0.54%)
Jul 9, 2026
12w ago
8-K
NEUTRAL ★ 2/10
$42.45 $39.12▼ −7.84%▼ −7.71%$30.13 (−29.03%)
Jul 7, 2026
12w ago
8-K
BULLISH ★ 7/10
$42.96 $43.13▲ +0.40%▼ −0.16%$30.13 (−29.88%)
Jun 11, 2026
16w ago
Institutional Cluster
BULLISH ★ 6/10
$33.65 $35.01▲ +4.04%▲ +3.61%$30.13 (−10.48%)
Jun 2, 2026
17w ago
8-K
BULLISH ★ 7/10
$31.26 $31.81▲ +1.76%▲ +4.72%$30.13 (−3.63%)
Jun 2, 2026
17w ago
Press Release
BULLISH ★ 7/10
$31.26 $31.81▲ +1.76%▲ +4.72%$30.13 (−3.63%)
May 7, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$35.88 $39.15▲ +9.11%▲ +7.61%$30.13 (−16.04%)
Feb 26, 2026
31w ago
8-K
MIXED ★ 7/10
$42.35 $38.85▼ −8.26%▼ −7.14%$30.13 (−28.87%)
Showing 10 of 17

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Feb 26, 2026